Rev Esp Quimioter 2025; 38(1): 1-7
Strengths and weaknesses of computerized clinical decision support systems: insights from a digital control center (C3 COVID-19) for early and personalized treatment for COVID-19
TOMMASO FRANCESCO AIELLO, CHRISTIAN TEIJON-LUMBRERAS, ANTONIO GALLARDO-PIZARRO, PATRICIA MONZÓ-GALLO, ANA MARTINEZ-URREA, GUILLERMO CUERVO, ANA DEL RIO, MARTA HERNÁNDEZ-MENESES, LAURA MORATA, JOSEP MENSA, ALEX SORIANO, CAROLINA GARCIA-VIDAL
Published: 29 October 2024
http://www.doi.org/10.37201/req/088.2024
Clinical Decision Support Systems (CDSS) are computer-based tools that leverage the analysis of large volumes of health data to assist healthcare professionals in making clinical decisions, whether preventive, diagnostic, or therapeutic. This review examines the impact of CDSS on clinical practice, highlighting both their potential benefits and their limitations and challenges. We detail the experience of clinical medical professionals in the development of a virtual control center for COVID-19 patients (C3 COVID-19) in Spain during the SARS-CoV-2 pandemic. This tool enabled real-time monitoring of clinical data for hospitalized COVID-19 patients, optimizing personalized and informed medical decision-making. CDSS can offer significant advantages, such as improving the quality of inpatient care, promoting evidence-based clinical and therapeutic decision-making, facilitating treatment personalization, and enhancing healthcare system efficiency and productivity. However, the implementation of CDSS presents challenges, including the need for physicians to become familiar with the systems and software, and the necessity for ongoing updates and technical support of the systems.
Rev Esp Quimioter 2025; 38(1): 1-7 [Full-text PDF]
